Who
Eric Morgen
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, BioAge Labs.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Apr 2024
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 18 Feb 2025filed 25 Feb 2025 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 25 Sep 2024filed 27 Sep 2024 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,952 at $0.00 | filing |
| 17 Apr 2024filed 27 Sep 2024 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —257,973 at $0.00 | filing |
| 17 Apr 2024filed 27 Sep 2024 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,598 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.